March 19, 2026: Eli Lilly announced TRANSCEND-T2D-1 topline results in adults with type 2 diabetes
Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
Across five positive Phase 3 studies, retatrutide has shown powerful efficacy, and we believe it could be an important future tool in the management of cardiometabolic health, Lilly Executive Vice President Kenneth Custer said in a statement
Collagen induction therapy, can improve the appearance and texture of your skin by stimulating your body to produce collagen
Rapid-onset swelling, breathlessness, or palpitations
Outcome misclassification : patients may label vulvar skin laxity, pelvic floor weakness, bleeding changes, and libido/arousal effects under the umbrella of vaginal changes, requiring clearer phenotyping